BioMap Appoints Former SAP Global VP Andy Deng as New President to Accelerate AI-Driven Life Science Commercialization

Today, BioMap announced the former SAP Global Vice PresidentMr. Deng Yongfu(Andy Deng) Appointed as President of BioMap, Fully Responsible for the Strategy, Operations, and Expansion of Life Science Intelligence Business.

He will lead the team to bring more advanced AI model capabilities to the life sciences industry based on BioMap's foundational large model for life sciences.

Mr. Deng Yongfu has accumulated over 20 years of rich experience in enterprise management and software commercialization. Before joining BioMap, he held key positions in well-known companies such as SAP and Kingdee Software Group.

SAP is the world's largest ERP management software supplier., repeatedly selected into the Fortune 500, SAP's total revenue in 2023 reached 31.207 billion euros.

During his 16-year tenure at SAP, he grew from a frontline account manager and sales director toVice President of China Region, Global Vice President, as the core leader of SAP China, successfully promoted significant development of SAP in the life sciences, consumer goods, retail, and real estate industries, creating several benchmark cases of digital transformation for industry-leading enterprises, leading SAP to maintain its position as an industry leader in the Chinese market for many consecutive years.

In 2021, Deng Yongfu joined Kingdee as the Vice President of Kingdee and General Manager of the Large Enterprise Business Group. He was fully responsible for the management of Kingdee Software's large enterprise business, led the strategic transformation and upgrading of the business, and successfully expanded and implemented several commercial cases with Fortune 500 companies.

The joining of Mr. Deng Yongfu also marks a new phase in the commercialization of BioMap.

BioMap has witnessed the development and transformation of the industry in the past three years: from the world's leading pharmaceutical companies being the first to embrace large AI models, to the rising enthusiasm of cutting-edge technical teams worldwide for AI model development, to the entire life sciences industry entering a rapid development phase of AI intelligence.

Currently, the demand for AI technology in China is significantly increasing in fields such as drug research and development, life health, biomanufacturing, education, and scientific research. This is especially true for the need to train advanced AI models using less data and without relying on underlying AI technology experts, and to utilize these models to optimize enterprises' R&D, experimentation, and production processes.

At the same time, these demands are also accelerating the leapfrog development of AI empowering China's life sciences industry. Mr. Deng Yongfu will utilize his deep industry experience and business insights to assist BioMap in building a life sciences intelligence business strategy based on the xTrimo large model platform, providing core products and supporting solutions related to AI models for customers in China, and facilitating their intelligent transformation.

Mr. Deng Yongfu said:"As a participant and witness in the development of China's IT industry and digital innovation, I am honored to join BioMap. Standing at the new starting point where AI meets life sciences, I look forward to working with the team to deepen the innovative commercial applications of AI in life sciences. We will bring our large AI life science models and successful customer service experiences to more Chinese enterprises, jointly promoting innovation and development in the field of life sciences."

Mr. Liu Wei, Co-founder and CEO of BioMap, stated:"The addition of Mr. Yongfu Deng will inject new momentum into BioMap's development in China and its expansion in the broader life sciences field. Mr. Yongfu Deng, along with BioMap International President Per Greisen, will design corresponding AI models, systems, and AI molecular design solutions tailored to the different needs of domestic and international clients based on the company’s large model platform. Together, they will accelerate the adoption of the company’s core technologies by clients and support their intelligent transformation."